Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma

Genes Chromosomes and Cancer

Volumn 52, Issue 6, 2013, Pages 538-550

  Mosquera, Juan Miguel ^a   Sboner, Andrea ^a   Zhang, Lei ^b   Kitabayashi, Naoki ^a   Chen, Chun Liang ^b   Sung, Yun Shao ^b   Wexler, Leonard H ^b   Laquaglia, Michael P ^b   Edelman, Morris ^c   Sreekantaiah, Chandrika ^c   Rubin, Mark A ^a   Antonescu, Cristina R ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Northshore LIJ Health System ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; NCOA1 PROTEIN; NCOA2 PROTEIN; PROTEIN; TRANSCRIPTION FACTOR PAX3; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE FUSION; GENE REARRANGEMENT; HUMAN; INFANT; INFANTILE SPINDLE CELL RHABDOMYOSARCOMA; KARYOTYPE; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; RNA SEQUENCE; SCHOOL CHILD; SPINDLE CELL; SPINDLE CELL SARCOMA;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEVUS, SPINDLE CELL; NUCLEAR RECEPTOR COACTIVATOR 2; PROGNOSIS; RHABDOMYOSARCOMA; SOFT TISSUE NEOPLASMS; YOUNG ADULT;

EID: 84876453998     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22050     Document Type: Article

References (48)

1. Azakie A, Lamont L, Fineman JR, He Y. 2005. Divergent transcriptional enhancer factor-1 regulates the cardiac troponin T promoter. Am J Physiol Cell Physiol 289: C1522-1534.
2. Calabrese G, Guanciali Franchi P, Stuppia L, Rossi C, Bianchi C, Antonucci A, Palka G. 1992. Translocation (8;11)(q12-13;q21) in embryonal rhabdomyosarcoma. Cancer Genet Cytogenet 58: 210-211.
3. Cavazzana AO, Schmidt D, Ninfo V, Harms D, Tollot M, Carli M, Treuner J, Betto R, Salviati G. 1992. Spindle cell rhabdomyosarcoma. A prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol 16: 229-235.
4. Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT, Aswad DW, Stallcup MR. 1999. Regulation of transcription by a protein methyltransferase. Science 284: 2174-2177.
5. Chiles MC, Parham DM, Qualman SJ, Teot LA, Bridge JA, Ullrich F, Barr FG, Meyer WH. 2004. Sclerosing rhabdomyosarcomas in children and adolescents: A clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group. Pediatr Dev Pathol 7: 583-594.
6. Debiec-Rychter M, Hagemeijer A, Sciot R. 2003. Spindle-cell rhabdomyosarcoma with 2q36 approximately q37 involvement. Cancer Genet Cytogenet 140: 62-65.
7. Folpe AL, McKenney JK, Bridge JA, Weiss SW. 2002. Sclerosing rhabdomyosarcoma in adults: Report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol 26: 1175-1183.
8. Gil-Benso R, Carda-Batalla C, Navarro-Fos S, Pellin-Perez A, Llombart-Bosch A. 1999. Cytogenetic study of a spindle-cell rhabdomyosarcoma of the parotid gland. Cancer Genet Cytogenet 109: 150-153.
9. Grundy R, Anderson J, Gaze M, Gerrard M, Glaser A, Gordon A, Malone M, Pritchard-Jones K, Michalski A. 2001. Congenital alveolar rhabdomyosarcoma: Clinical and molecular distinction from alveolar rhabdomyosarcoma in older children. Cancer 91: 606-612.
10. Habegger L, Sboner A, Gianoulis TA, Rozowsky J, Agarwal A, Snyder M, Gerstein M. 2011. RSEQtools: A modular framework to analyze RNA-Seq data using compact, anonymized data summaries. Bioinformatics 27: 281-283.
11. Hayashi Y, Inaba T, Hanada R, Yamamoto K. 1988. Translocation 2;8 in a congenital rhabdomyosarcoma. Cancer Genet Cytogenet 30: 343-345.
12. Ho RH, Johnson J, Dev VG, Whitlock JA. 2004. A novel t(2;20)(q35;p12) in embryonal rhabdomyosarcoma. Cancer Genet Cytogenet 151: 73-77.
13. Hosoi H, Kakazu N, Konishi E, Tsuchihashi Y, Hada S, Amaya E, Nakabayahi Y, Misawa-Furihata A, Tabata-Maruyama H, Iehara T, Sugimoto T, Yamane H, Yamasaki M, Shiwaku K, Yanagisawa A, Ono M, Tokiwa K, Iwai N, Hashiba M, Abe T, Sawada T. 2009. A novel PAX3 rearrangement in embryonal rhabdomyosarcoma. Cancer Genet Cytogenet 189: 98-104.
14. Hsu F, Kent WJ, Clawson H, Kuhn RM, Diekhans M, Haussler D. 2006. The UCSC Known Genes. Bioinformatics 22: 1036-1046.
15. Jin Y, Moller E, Nord KH, Mandahl N, Von Steyern FV, Domanski HA, Marino-Enriquez A, Magnusson L, Nilsson J, Sciot R, Fletcher CD, Debiec-Rychter M, Mertens F. 2012. Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes. Genes Chromosomes Cancer 51: 510-520.
16. Koh SS, Chen D, Lee YH, Stallcup MR. 2001. Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J Biol Chem 276: 1089-1098.
17. Leuschner I, Newton WA, Jr., Schmidt D, Sachs N, Asmar L, Hamoudi A, Harms D, Maurer HM. 1993. Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region. A report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol 17: 221-230.
18. Li S, Czubryt MP, McAnally J, Bassel-Duby R, Richardson JA, Wiebel FF, Nordheim A, Olson EN. 2005. Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice. Proc Natl Acad Sci USA 102: 1082-1087.
19. Lobe TE, Wiener ES, Hays DM, Lawrence WH, Andrassy RJ, Johnston J, Wharam M, Webber B, Ragab A. 1994. Neonatal rhabdomyosarcoma: The IRS experience. J Pediatr Surg 29: 1167-1170.
20. Meloni-Ehrig A, Smith B, Zgoda J, Greenberg J, Perdahl-Wallace E, Zaman S, Mowrey P. 2009. Translocation (2;8)(q35;q13): A recurrent abnormality in congenital embryonal rhabdomyosarcoma. Cancer Genet Cytogenet 191: 43-45.
21. Mentrikoski M, Golden W, Bourne T, LeGallo R. Pediatr Dev Pathol (in press).
22. Mentzel T. 2010. [Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignant mesenchymal tumors of soft tissues]. Pathologe 31: 91-96.
23. Mentzel T, Katenkamp D. 2000. Sclerosing, pseudovascular rhabdomyosarcoma in adults. Clinicopathological and immunohistochemical analysis of three cases. Virchows Arch 436: 305-311.
24. Mentzel T, Kuhnen C. 2006. Spindle cell rhabdomyosarcoma in adults: Clinicopathological and immunohistochemical analysis of seven new cases. Virchows Arch 449: 554-560.
25. Molkentin JD, Black BL, Martin JF, Olson EN. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83: 1125-1136.
26. Moriyama M, Shuin T, Kubota Y, Satomi Y, Sugio Y, Kuroki Y. 1986. A case of rhabdomyosarcoma of the bladder with a (2;5) chromosomal translocation in peripheral lymphocytes. Cancer Genet Cytogenet 22: 177-181.
27. Nascimento AF, Fletcher CD. 2005. Spindle cell rhabdomyosarcoma in adults. Am J Surg Pathol 29: 1106-1113.
28. Owens GK, Kumar MS, Wamhoff BR. 2004. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801.
29. Pflueger D, Terry S, Sboner A, Habegger L, Esgueva R, Lin PC, Svensson MA, Kitabayashi N, Moss BJ, MacDonald TY, Cao X, Barrette T, Tewari AK, Chee MS, Chinnaiyan AM, Rickman DS, Demichelis F, Gerstein MB, Rubin MA. 2011. Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Res 21: 56-67.
30. Pierron G, Tirode F, Lucchesi C, Reynaud S, Ballet S, Cohen-Gogo S, Perrin V, Coindre JM, Delattre O. 2012. A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nat Genet 44: 461-466.
31. Pipes GC, Creemers EE, Olson EN. 2006. The myocardin family of transcriptional coactivators: Versatile regulators of cell growth, migration, and myogenesis. Genes Dev 20: 1545-1556.
32. Qiu H, Wang F, Liu C, Xu X, Liu B. 2011. TEAD1-dependent expression of the FoxO3a gene in mouse skeletal muscle. BMC Mol Biol 12: 1.
33. Quail MA, Kozarewa I, Smith F, Scally A, Stephens PJ, Durbin R, Swerdlow H, Turner DJ. 2008. A large genome center's improvements to the Illumina sequencing system. Nat Methods 5: 1005-1010.
34. Rodriguez-Galindo C, Hill DA, Onyekwere O, Pin N, Rao BN, Hoffer FA, Kun LE, Pappo AS, Santana VM. 2001. Neonatal alveolar rhabdomyosarcoma with skin and brain metastases. Cancer 92: 1613-1620.
35. Rubin BP, Hasserjian RP, Singer S, Janecka I, Fletcher JA, Fletcher CD. 1998. Spindle cell rhabdomyosarcoma (so-called) in adults: Report of two cases with emphasis on differential diagnosis. Am J Surg Pathol 22: 459-464.
36. Sboner A, Habegger L, Pflueger D, Terry S, Chen DZ, Rozowsky JS, Tewari AK, Kitabayashi N, Moss BJ, Chee MS, Demichelis F, Rubin MA, Gerstein MB. 2010. FusionSeq: A modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data. Genome Biol 11: R104.
37. Strehl S, Nebral K, Konig M, Harbott J, Strobl H, Ratei R, Struski S, Bielorai B, Lessard M, Zimmermann M, Haas OA, Izraeli S. 2008. ETV6-NCOA2: A novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations. Clin Cancer Res 14: 977-983.
38. Sumegi J, Streblow R, Frayer RW, Dal Cin P, Rosenberg A, Meloni-Ehrig A, Bridge JA. 2010. Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Genes Chromosomes Cancer 49: 224-236.
39. Tanas MR, Sboner A, Oliveira AM, Erickson-Johnson MR, Hespelt J, Hanwright PJ, Flanagan J, Luo Y, Fenwick K, Natrajan R, Mitsopoulos C, Zvelebil M, Hoch BL, Weiss SW, Debiec-Rychter M, Sciot R, West RB, Lazar AJ, Ashworth A, Reis-Filho JS, Lord CJ, Gerstein MB, Rubin MA, Rubin BP. 2011. Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med 3: 98ra82.
40. Troke PJ, Kindle KB, Collins HM, Heery DM. 2006. MOZ fusion proteins in acute myeloid leukaemia. Biochem Soc Symp 23-39.
41. Wachtel M, Dettling M, Koscielniak E, Stegmaier S, Treuner J, Simon-Klingenstein K, Buhlmann P, Niggli FK, Schafer BW. 2004. Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1. Cancer Res 64: 5539-5545.
42. Wang L, Motoi T, Khanin R, Olshen A, Mertens F, Bridge J, Dal Cin P, Antonescu CR, Singer S, Hameed M, Bovee JV, Hogendoorn PC, Socci N, Ladanyi M. 2012. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer 51: 127-139.
43. Whang-Peng J, Triche TJ, Knutsen T, Miser J, Kao-Shan S, Tsai S, Israel MA. 1986. Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet 21: 185-208.
44. Williamson D, Missiaglia E, de Reynies A, Pierron G, Thuille B, Palenzuela G, Thway K, Orbach D, Lae M, Freneaux P, Pritchard-Jones K, Oberlin O, Shipley J, Delattre O. 2010. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol 28: 2151-2158.
45. Xu J, O'Malley BW. 2002. Molecular mechanisms and cellular biology of the steroid receptor coactivator (SRC) family in steroid receptor function. Rev Endocr Metab Disord 3: 185-192.
46. Yoshida T, Owens GK. 2005. Molecular determinants of vascular smooth muscle cell diversity. Circ Res 96: 280-291.
47. Yoshino K, Takeuchi M, Nakayama M, Suehara N. 2005. Congenital cervical rhabdomyosarcoma arising in one fetus of a twin pregnancy. Fetal Diagn Ther 20: 291-295.
48. Zambrano E, Perez-Atayde AR, Ahrens W, Reyes-Mugica M. 2006. Pediatric sclerosing rhabdomyosarcoma. Int J Surg Pathol 14: 193-199.